We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ONCO3 market cap is 4.08B. The company's latest EPS is BRL 0.4239 and P/E is 18.38.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | ||
Total Revenue | 1.22B | 1.29B | 1.36B | 1.4B | 1.44B |
Operating Income | 164.76M | 208.75M | 188.52M | 183.05M | 128.37M |
Net Income | 4.58M | 22.18M | 21.01M | 104.99M | 75.44M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Total Revenue | 2.04B | 2.7B | 4.09B | 5.5B |
Operating Income | 19.62M | 177.22M | 470.57M | 758.02M |
Net Income | -159.62M | -46.9M | 46.26M | 223.62M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | ||
Total Assets | 8.22B | 8.27B | 8.56B | 8.61B | 9.18B |
Total Liabilities | 5.59B | 5.72B | 5.79B | 5.96B | 6.5B |
Total Equity | 2.63B | 2.55B | 2.77B | 2.65B | 2.68B |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Total Assets | 3.36B | 6.03B | 8.22B | 9.18B |
Total Liabilities | 2.69B | 3.73B | 5.59B | 6.5B |
Total Equity | 677.31M | 2.3B | 2.63B | 2.68B |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | ||
Operating | -271.64M | -246.75M | -70.76M | 152.79M | -51.56M |
Investing | -408.72M | 423.47M | 447.94M | 507.04M | 227.83M |
Financing | 407.08M | -30.02M | -89.68M | -372.24M | 111.42M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Operating | 97.56M | -9.28M | -271.64M | -51.56M |
Investing | -355.24M | -2.03B | -408.72M | 227.83M |
Financing | 551.12M | 1.83B | 407.08M | 111.42M |
Market Cap | 4.08B |
Price to Earnings Ratio | 18.38 |
Price to Sales Ratio | 0.75 |
Price to Cash Ratio | 7.46 |
Price to Book Ratio | 1.53 |
Dividend Yield | - |
Shares Outstanding | 527.48M |
Average Volume (1 week) | 10.8M |
Average Volume (1 Month) | 6.8M |
52 Week Change | -28.27% |
52 Week High | 13.00 |
52 Week Low | 5.38 |
Spread (Intraday) | 0.01 (0.13%) |
Company Name | Oncoclinicas Brasil Servicos Medico |
Address |
avenida presidente juscelino kubitschek n 510 sao paulo, sao paulo 04543-906 |
Website | https://grupooncoclinicas.com |
Industry | gen med & surgical hospitals (8062) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions